Finance

Beta
Lists
NAUT:NASDAQ
Nautilus Biotechnology Inc
2,28 USD
+1,11%
(+0,025) 1D
11-июн., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAUT...
Open
2,28 USD
High
2,39 USD
Low
2,25 USD
Mkt. cap
290,38 ПНн
Avg. vol.
400,93 Пиң
Volume
0,00
52-wk high
4,31 USD
52-wk low
0,62 USD
EPS
-0,45 USD
Beta
0,75
Shares outstanding
127,08 ПНн
No. of employees
127
Open
2,28 USD
High
2,39 USD
Low
2,25 USD
Mkt. cap
290,38 ПНн
Avg. vol.
400,93 Пиң
Volume
0,00
52-wk high
4,31 USD
52-wk low
0,62 USD
EPS
-0,45 USD
Beta
0,75
Shares outstanding
127,08 ПНн
No. of employees
127
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to NAUT in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for NAUT in the last 3 months.
Highest
Current 2,28 USD
4,00 USD (+75,05%)
Average
4,00 USD (+75,05%)
Lowest
4,00 USD (+75,05%)
News stories
From sources across the web
About Nautilus Biotechnology Inc
CEO-
Employees127
Founded2016
HeadquartersСиэтл, Вашингтон, Америка Кошмо Штаттары
SectorHealth care
Last report
2025-ж., 29-апр.
Fiscal period
Q1 2025
EPS / Est. (USD)
-0,13 USD / -0,14 USD
+4,88%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q1 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-М. сон.
2025-М. док.
2026-ж. мар.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10,39 ПНн
9,60 ПНн
9,58 ПНн
9,71 ПНн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,70 ПНн
5,87 ПНн
5,85 ПНн
6,42 ПНн
Operating expense
17,10 ПНн
15,47 ПНн
15,42 ПНн
16,12 ПНн
Total operating expenses
17,10 ПНн
15,47 ПНн
15,42 ПНн
16,12 ПНн
Operating income
-17,10 ПНн
-15,47 ПНн
-15,42 ПНн
-16,12 ПНн
Other non operating income
-16,00 Пиң
-5,00 Пиң
-145,00 Пиң
-15,00 Пиң
EBT including unusual items
-15,03 ПНн
-13,57 ПНн
-13,78 ПНн
-14,70 ПНн
EBT excluding unusual items
-15,03 ПНн
-13,57 ПНн
-13,92 ПНн
-14,70 ПНн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15,03 ПНн
-13,57 ПНн
-13,78 ПНн
-14,70 ПНн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2,08 ПНн
1,90 ПНн
1,65 ПНн
1,44 ПНн
Interest expense
-
-
-
-
Net interest expenses
2,08 ПНн
1,90 ПНн
1,65 ПНн
1,44 ПНн
Depreciation and amortization charges
-
-
-
-
EBITDA
-16,64 ПНн
-15,05 ПНн
-15,02 ПНн
-15,79 ПНн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more